Nvwm, LLC Obs Eva Sa Transaction History

Nvwm, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$2.48 - $8.1 $3,305 - $10,797	-1,333 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$10.05 - $14.25 $5,025 - $7,125	500 Added 60.02%	1,333 $15,000
Q4 2018 Jan 29, 2019	BUY	$10.8 - $17.94 $3,596 - $5,974	333 Added 66.6%	833 $11,000
Q3 2018 Nov 14, 2018	BUY	$10.92 - $18.18 $5,460 - $9,090	500 New	500 $9,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Nvwm, LLC with notifications on news.